AngioDynamics, Inc. ANGO
11.73 USD -0.08 (-0.68%)
At closeNov 6, 2026, 4:01 PM EST
11.73 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
11.55 Day range 11.81
9.70 52-week range 16.13
- YTD
- -8.64%
- 1 year
- 0.00%
News
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares…
benzinga.com AngioDynamics Reports DIRECT Study Findings Showing Longer Overall Survival In Stage III Pancreatic Ductal Adenocarcinoma, Gets Category I CPT Code For Open IRE Ablation Of Pancreatic Tumors, Effective January 1, 2027 Prospective, multicenter FDA IDE study found an IRE-based treatment strategy was associated with longer overall survival in Stage III pancreatic cancer; new Category I CPT code for open pancreatic…
benzinga.com HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18 HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $19 to $18.
benzinga.com AngioDynamics Stock Is Falling Thursday: What's Going On? ANGO stock drops 21% as AngioDynamics reports Q1 results, names Eric Honroth as new CEO, and reaffirms FY27 guidance.
benzinga.com Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo beat estimates but cut FY26 outlook; oil jumped 5%.
benzinga.com AngioDynamics Q1 2027 Earnings Call: Complete Transcript AngioDynamics (NASDAQ:ANGO) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to…
benzinga.com Earnings Scheduled For October 8, 2026 Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss at $0.15 per share on revenue of $266.42 million. • Helen Of Troy (NASDAQ:HELE) is projected to…
benzinga.com AngioDynamics Appoints Eric Honroth As President And CEO, Effective November 2 Mr. Honroth will succeed Jim Clemmer, who will depart the Board on November 2, 2026, and will remain in a consulting capacity to ensure a smooth transition.The appointment follows a Board-led search…
benzinga.com AngioDynamics Affirms FY2027 Adj EPS Guidance of $(0.29)-$(0.24) vs $(0.27) Est; Affirms FY2027 Sales Guidance of $336.000M-$341.000M vs $337.400M Est AngioDynamics (NASDAQ:ANGO) affirms FY2027 Adj EPS guidance from $(0.29)-$(0.24) to $(0.29)-$(0.24) vs $(0.27) analyst estimate. Affirms FY2027 sales outlook from $336.000 million-$341.000 million to…
benzinga.com AngioDynamics Q1 Adj. EPS $(0.04) Beats $(0.11) Estimate, Sales $80.915M Beat $80.500M Estimate AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.11) by 63.64 percent. This is a 60 percent increase over losses of $(0.10)…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million. Omeros (NASDAQ:OMER) stock…
- benzinga.com HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19 HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from $16 to $19.
- benzinga.com Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20 Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from $16 to $20.
- benzinga.com Full Transcript: AngioDynamics Q4 2026 Earnings Call AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For…
- benzinga.com Earnings Scheduled For July 14, 2026 Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarterly earnings at $3.25 per share on revenue of $862.92 million. • JPMorgan Chase (NYSE:JPM) is…
- benzinga.com AngioDynamics Sees FY2027 Adj EPS $(0.29)-$(0.24) vs $(0.16) Est; Sees Sales $336.000M-$341.000M vs $329.600M Est AngioDynamics (NASDAQ:ANGO) is looking for FY2027 Adj EPS of $(0.29)-$(0.24) vs $(0.16) analyst estimate. sees sales of $336.000 million-$341.000 million vs $329.600 million analyst estimate.
benzinga.com AngioDynamics Q4 Adj. EPS $(0.07) Beats $(0.09) Estimate, Sales $86.607M Beat $80.400M Estimate AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 133.33 percent decrease over losses of…- benzinga.com AngioDynamics Says FDA Approves IDE Application To Initiate RELIEF Study Evaluating NanoKnife IRE Platform As Minimally Invasive Treatment Option For Men With Benign Prostatic Hyperplasia AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality…
benzinga.com Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock jumped 11.73%.- benzinga.com AngioDynamics Announces 2-Yr Results From PRESERVE Pivotal Trial Demonstrating Durable Oncologic Control And Sustained Safety Profile For NanoKnife System In Focal Ablation Of Intermediate-Risk Prostate Cancer Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented at AUA 2026AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring…
- benzinga.com Earnings Scheduled For April 2, 2026
benzinga.com Acuity, Lindsay And 3 Stocks To Watch Heading Into Thursday U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Corp expected to post earnings, Globalstar shares jump after Amazon acquisition talks, AngioDynamics…
benzinga.com Dow Jumps Over 400 Points; US Services Activity Falls In December 
benzinga.com US Stocks Mixed; Nasdaq Gains Over 50 Points 
benzinga.com Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results 
benzinga.com Stock Market Today: Dow Futures Slip, S&P 500 Rises Amid Mixed Trade—Berkshire, Occidental, Fermi In Focus U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed.
benzinga.com Earnings Scheduled For July 15, 2025 - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Gold Moves Higher; US Private Sector Job Growth Tops Estimates 
benzinga.com Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - benzinga.com Earnings Scheduled For April 2, 2025
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Crude Oil Down 1%; US Weekly Jobless Claims Decline - benzinga.com Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- benzinga.com Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 - benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 188 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 345 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 286 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 497 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 116 companies set new 52-week lows.
- benzinga.com Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and…
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 167 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 107 stocks hit new 52-week lows.
- benzinga.com Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
- benzinga.com Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday's Mid-Day Session Gainers Cosmos Holdings Inc. (NASDAQ: COSM) rose 68% to $0.5500 after surging around 87% on Tuesday. Cosmos Holdings recently posted a Q3 loss of $0.08 per share.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 446 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 404 stocks made new 52-week lows.